JP2019505554A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019505554A5 JP2019505554A5 JP2018543637A JP2018543637A JP2019505554A5 JP 2019505554 A5 JP2019505554 A5 JP 2019505554A5 JP 2018543637 A JP2018543637 A JP 2018543637A JP 2018543637 A JP2018543637 A JP 2018543637A JP 2019505554 A5 JP2019505554 A5 JP 2019505554A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- antagonist
- infection
- dose
- doses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022152120A JP7813209B2 (ja) | 2016-02-19 | 2022-09-26 | Il-4rアンタゴニストを投与することによるワクチンの有効性を増強する方法 |
| JP2024087570A JP2024112987A (ja) | 2016-02-19 | 2024-05-30 | Il-4rアンタゴニストを投与することによるワクチンの有効性を増強する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662297257P | 2016-02-19 | 2016-02-19 | |
| US62/297,257 | 2016-02-19 | ||
| US201662409936P | 2016-10-19 | 2016-10-19 | |
| US62/409,936 | 2016-10-19 | ||
| PCT/US2017/018487 WO2017143270A1 (en) | 2016-02-19 | 2017-02-17 | Methods for enhancing efficacy of a vaccine by administering an il-4r antagonist |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022152120A Division JP7813209B2 (ja) | 2016-02-19 | 2022-09-26 | Il-4rアンタゴニストを投与することによるワクチンの有効性を増強する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019505554A JP2019505554A (ja) | 2019-02-28 |
| JP2019505554A5 true JP2019505554A5 (cg-RX-API-DMAC7.html) | 2020-03-26 |
| JP7597500B2 JP7597500B2 (ja) | 2024-12-10 |
Family
ID=58192407
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018543637A Active JP7597500B2 (ja) | 2016-02-19 | 2017-02-17 | Il-4rアンタゴニストを投与することによるワクチンの有効性を増強する方法 |
| JP2022152120A Active JP7813209B2 (ja) | 2016-02-19 | 2022-09-26 | Il-4rアンタゴニストを投与することによるワクチンの有効性を増強する方法 |
| JP2024087570A Abandoned JP2024112987A (ja) | 2016-02-19 | 2024-05-30 | Il-4rアンタゴニストを投与することによるワクチンの有効性を増強する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022152120A Active JP7813209B2 (ja) | 2016-02-19 | 2022-09-26 | Il-4rアンタゴニストを投与することによるワクチンの有効性を増強する方法 |
| JP2024087570A Abandoned JP2024112987A (ja) | 2016-02-19 | 2024-05-30 | Il-4rアンタゴニストを投与することによるワクチンの有効性を増強する方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US10314904B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3416685B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7597500B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102868264B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN109069625A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2017220184B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3014202A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2983475T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE067673T2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL261025A (cg-RX-API-DMAC7.html) |
| MA (1) | MA44238B1 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2018009990A (cg-RX-API-DMAC7.html) |
| PL (1) | PL3416685T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT3416685T (cg-RX-API-DMAC7.html) |
| RU (1) | RU2753869C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017143270A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201805295B (cg-RX-API-DMAC7.html) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| KR102502640B1 (ko) | 2012-08-21 | 2023-02-23 | 사노피 바이오테크놀로지 | Il-4r 길항제의 투여에 의한 천식의 치료 또는 예방 방법 |
| CN118286417A (zh) | 2012-09-07 | 2024-07-05 | 瑞泽恩制药公司 | 以il-4r拮抗剂治疗特应性皮炎的方法 |
| TWI755763B (zh) | 2013-06-04 | 2022-02-21 | 美商再生元醫藥公司 | 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法 |
| TWI634900B (zh) | 2013-07-11 | 2018-09-11 | 再生元醫藥公司 | 藉由投與il-4r抑制劑治療嗜酸性食道炎的方法 |
| IL315136A (en) | 2014-02-21 | 2024-10-01 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an il-4rantagonist |
| PT3110848T (pt) | 2014-09-24 | 2024-03-05 | Regeneron Pharma | Métodos para tratamento de infeção cutânea por administração de um antagonista do il-4r |
| CA3246946A1 (en) | 2014-11-14 | 2025-11-29 | Sanofi Biotechnology | Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist |
| EP3454878A4 (en) * | 2016-05-10 | 2020-07-29 | Hennepin Healthcare Research Institute | CYTOKINE IMMUNOMODULATORS AND SIGNALING METHODS |
| KR102872485B1 (ko) * | 2016-09-01 | 2025-10-20 | 리제너론 파아마슈티컬스, 인크. | Il-4r 길항제를 투여함에 의해 알레르기를 예방하거나 치료하기 위한 방법 |
| WO2019028367A1 (en) | 2017-08-04 | 2019-02-07 | Regeneron Pharmaceuticals, Inc. | METHODS OF TREATING ESOPHAGITIS WITH ACTIVE EOSINOPHILES |
| PT3515465T (pt) | 2017-08-18 | 2024-03-04 | Regeneron Pharma | Métodos para o tratamento de uma dermatite atópica grave mediante a administração de um inibidor de il-4r |
| US11034768B2 (en) | 2017-10-30 | 2021-06-15 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an IL-4R antagonist |
| MX2020012064A (es) | 2018-05-13 | 2021-04-13 | Regeneron Pharma | Metodos para tratar la dermatitis atopica administrando un inhibidor de il-4r. |
| WO2020092015A1 (en) | 2018-11-02 | 2020-05-07 | University Of Rochester | Therapeutic mitigation of epithelial infection |
| MA55204A (fr) * | 2019-03-06 | 2022-01-12 | Regeneron Pharma | Inhibiteurs de la voie il-4/il-13 pour une efficacité améliorée dans le traitement du cancer |
| KR20210143246A (ko) | 2019-03-21 | 2021-11-26 | 리제너론 파아마슈티컬스, 인크. | 알레르기 치료용 il-4/il-13 경로 억제제 및 형질 세포 절제의 병용 |
| KR20220034878A (ko) | 2019-07-16 | 2022-03-18 | 사노피 바이오테크놀로지 | Il-4r 길항제를 투여하여 천식을 치료 또는 예방하는 방법 |
| US11504426B2 (en) | 2019-08-05 | 2022-11-22 | Regeneron Pharmaceuticals, Inc. | Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist |
| JP7736667B2 (ja) | 2019-08-05 | 2025-09-09 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | Il-4rアンタゴニストを投与することによるアトピー性皮膚炎の治療方法 |
| EP3992974A1 (en) | 2020-11-02 | 2022-05-04 | Sanofi Biotechnology | Methods for treating digitally-identified il-4/il-13 related disorders |
| CA3161037A1 (en) | 2019-12-09 | 2021-06-17 | Sanofi Biotechnology | Methods for treating digitally-identified il-4/il-13 related disorders |
| KR20220158821A (ko) * | 2020-03-27 | 2022-12-01 | 리제너론 파아마슈티컬스, 인크. | Il-4r 길항제를 투여함에 의해 아토피 피부염을 치료하기 위한 방법 |
| WO2023004420A1 (en) * | 2021-07-22 | 2023-01-26 | Icahn School Of Medicine At Mount Sinai | Dual-blockade of il-4 signaling and immune checkpoint proteins for treating cancer |
| US20230167171A1 (en) * | 2021-08-23 | 2023-06-01 | Regeneron Pharmaceuticals, Inc. | Methods for treating atopic dermatitis by administering an il-4r antagonist |
| CN118717989A (zh) * | 2024-05-27 | 2024-10-01 | 中国人民解放军军事科学院军事医学研究院 | Il-4r拮抗剂在制备预防和/或治疗流感病毒感染的药物中的应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2990420T (pt) | 2000-05-26 | 2017-03-16 | Immunex Corp | Uso de anticorpos de recetor de interleucina-4 e composições dos mesmos |
| AU2002360278A1 (en) | 2001-10-12 | 2003-11-11 | Coley Pharmaceutical Gmbh | Methods and products for enhancing immune responses using imidazoquinoline compounds |
| GB0217920D0 (en) * | 2002-04-23 | 2002-09-11 | Aventis Pharm Prod Inc | Interleukin-4 Gene Expression inhibitors |
| UA93653C2 (ru) | 2003-11-07 | 2011-03-10 | Иммунекс Корпорейшн | Выделенное антитело, kotopoe специфически связывается c человеческим рецептором il-4 (il-4r) |
| US7608693B2 (en) * | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| CA2664343C (en) | 2006-10-02 | 2016-04-26 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human il-4 receptor |
| US8092804B2 (en) | 2007-12-21 | 2012-01-10 | Medimmune Limited | Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| MX2010006735A (es) | 2007-12-21 | 2010-09-30 | Medimmune Ltd | Miembros de union para receptor alfa de interleucina-4 (il-4ra) - 173. |
| EP2414520A2 (en) | 2009-03-31 | 2012-02-08 | Altair Therapeutics, Inc. | Methods of modulating an immune response to a viral infection |
| MX366337B (es) | 2010-10-06 | 2019-07-05 | Regeneron Pharma | Formulaciones estabilizadas que contienen anticuerpos anti-receptor de interleucina-4 (il-4r). |
| HK1203358A1 (en) * | 2012-06-05 | 2015-10-30 | The Australian National University | Vaccination with interleukin-4 antagonists |
| CN118286417A (zh) * | 2012-09-07 | 2024-07-05 | 瑞泽恩制药公司 | 以il-4r拮抗剂治疗特应性皮炎的方法 |
| TWI755763B (zh) | 2013-06-04 | 2022-02-21 | 美商再生元醫藥公司 | 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法 |
| RS59354B1 (sr) * | 2013-06-21 | 2019-10-31 | Sanofi Biotechnology | Postupci lečenja nosne polipoze davanjem il-4r antagonista |
| KR20190062142A (ko) * | 2017-11-28 | 2019-06-05 | (주)비티엔 | 면역 증강 활성을 가지는 아미노산 미네랄 복합체 및 이를 포함하는 식품, 약학 또는 사료용 조성물 |
| US20210361700A1 (en) * | 2020-05-22 | 2021-11-25 | Trustees Of Tufts College | Nutritional supplement to combat covid-19 and aid vaccination |
-
2017
- 2017-02-17 EP EP17708398.7A patent/EP3416685B1/en not_active Revoked
- 2017-02-17 EP EP24174931.6A patent/EP4420733A3/en not_active Withdrawn
- 2017-02-17 AU AU2017220184A patent/AU2017220184B2/en active Active
- 2017-02-17 PT PT177083987T patent/PT3416685T/pt unknown
- 2017-02-17 US US15/436,032 patent/US10314904B2/en active Active
- 2017-02-17 CA CA3014202A patent/CA3014202A1/en active Pending
- 2017-02-17 KR KR1020187026017A patent/KR102868264B1/ko active Active
- 2017-02-17 CN CN201780014809.1A patent/CN109069625A/zh active Pending
- 2017-02-17 MX MX2018009990A patent/MX2018009990A/es unknown
- 2017-02-17 RU RU2018133011A patent/RU2753869C2/ru active
- 2017-02-17 HU HUE17708398A patent/HUE067673T2/hu unknown
- 2017-02-17 WO PCT/US2017/018487 patent/WO2017143270A1/en not_active Ceased
- 2017-02-17 PL PL17708398.7T patent/PL3416685T3/pl unknown
- 2017-02-17 ES ES17708398T patent/ES2983475T3/es active Active
- 2017-02-17 JP JP2018543637A patent/JP7597500B2/ja active Active
- 2017-02-17 MA MA44238A patent/MA44238B1/fr unknown
-
2018
- 2018-08-07 IL IL261025A patent/IL261025A/en unknown
- 2018-08-10 ZA ZA2018/05295A patent/ZA201805295B/en unknown
- 2018-08-17 MX MX2024010676A patent/MX2024010676A/es unknown
-
2019
- 2019-04-29 US US16/398,143 patent/US20190321457A1/en not_active Abandoned
-
2022
- 2022-09-26 JP JP2022152120A patent/JP7813209B2/ja active Active
-
2023
- 2023-07-05 US US18/218,459 patent/US20240082380A1/en not_active Abandoned
-
2024
- 2024-05-30 JP JP2024087570A patent/JP2024112987A/ja not_active Abandoned
- 2024-07-18 AU AU2024204962A patent/AU2024204962A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7813209B2 (ja) | Il-4rアンタゴニストを投与することによるワクチンの有効性を増強する方法 | |
| Wagner et al. | Vaccines to prevent infectious diseases in the older population: immunological challenges and future perspectives | |
| US10406220B2 (en) | Pneumococcal dosing regimen | |
| Plotkin et al. | The development of vaccines: how the past led to the future | |
| Locht | Live pertussis vaccines: will they protect against carriage and spread of pertussis? | |
| Moore | Developing vaccines to combat human diseases: a history | |
| Moylett et al. | 29. Immunization | |
| Hay | What you need to know | |
| Ottolini | Current and future use of vaccines for viral and bacterial respiratory tract infections | |
| Backx et al. | Immunization | |
| Weinberger | Vaccines and vaccination strategies for older adults | |
| AbdelAllah et al. | A combined inactivated cholera and hepatitis A vaccine-induced potent protective immunity in a mouse model | |
| HK40117172A (en) | Methods for enhancing efficacy of a vaccine by administering an il-4r antagonist | |
| Mishra | 43 Recent Advances for Immunotherapies Against Infectious Disease | |
| Yaragudi et al. | Application of Inhaled Biologics as Vaccines, Part 4 | |
| CN117562989A (zh) | 用疫苗控制感染性疾病的方法 | |
| Raya et al. | 153. The Effect of Timing of Tetanus–Diphtheria and Pertussis Vaccine Administration in Pregnancy on The Avidity of Pertussis Antibodies | |
| Miranda | Early Childhood Vaccination Schedules in European Union Countries: A Review | |
| MOON | Pertussis Booster Protects Teens Beyond 5 Years | |
| HK40001760A (en) | Methods for enhancing efficacy of a vaccine by administering an il-4r antagonist | |
| HK40001760B (en) | Methods for enhancing efficacy of a vaccine by administering an il-4r antagonist | |
| Bhat et al. | Adolescent Vaccines |